Hyperuricemia	B:C0740394
after	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
:	O
divergent	O
associations	O
with	O
progression	O
of	O
renal	O
disease	I:C0022658
,	O
incident	O
end	O
-	I:C0022661
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
,	O
and	O
mortality	O
.	O

Hyperuricemia	O
after	O
orthotopic	B:C0400447
liver	I:C0400447
transplantation	I:C0400447
:	O
divergent	O
associations	O
with	O
progression	O
of	O
renal	O
disease	I:C0022658
,	O
incident	O
end	O
-	I:C0022661
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
,	O
and	O
mortality	O
.	O

Hyperuricemia	O
after	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
:	O
divergent	O
associations	O
with	O
progression	B:C0242656
of	O
renal	O
disease	I:C0022658
,	O
incident	O
end	O
-	I:C0022661
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
,	O
and	O
mortality	O
.	O

Hyperuricemia	O
after	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
:	O
divergent	O
associations	O
with	O
progression	O
of	O
renal	B:C0022658
disease	I:C0022658
,	O
incident	O
end	O
-	I:C0022661
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
,	O
and	O
mortality	O
.	O

Hyperuricemia	O
after	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
:	O
divergent	O
associations	O
with	O
progression	O
of	O
renal	O
disease	I:C0022658
,	O
incident	O
end	B:C0022661
-	I:C0022661
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
,	O
and	O
mortality	O
.	O

Although	O
hyperuricemia	B:C0740394
is	O
common	O
after	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
(	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
)	O
,	O
its	O
relationship	O
to	O
mortality	O
,	O
progressive	O
kidney	O
disease	I:C0022658
,	O
or	O
the	O
development	O
of	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
(	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
)	O
is	O
not	O
well	O
-	O
described	O
.	O

Although	O
hyperuricemia	O
is	O
common	O
after	O
orthotopic	B:C0400447
liver	I:C0400447
transplantation	I:C0400447
(	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
)	O
,	O
its	O
relationship	O
to	O
mortality	O
,	O
progressive	O
kidney	O
disease	I:C0022658
,	O
or	O
the	O
development	O
of	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
(	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
)	O
is	O
not	O
well	O
-	O
described	O
.	O

Although	O
hyperuricemia	O
is	O
common	O
after	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
(	O
orthotopic	B:C0400447
liver	I:C0400447
transplantation	I:C0400447
)	O
,	O
its	O
relationship	O
to	O
mortality	O
,	O
progressive	O
kidney	O
disease	I:C0022658
,	O
or	O
the	O
development	O
of	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
(	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
)	O
is	O
not	O
well	O
-	O
described	O
.	O

Although	O
hyperuricemia	O
is	O
common	O
after	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
(	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
)	O
,	O
its	O
relationship	O
to	O
mortality	O
,	O
progressive	O
kidney	B:C0022658
disease	I:C0022658
,	O
or	O
the	O
development	O
of	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
(	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
)	O
is	O
not	O
well	O
-	O
described	O
.	O

Although	O
hyperuricemia	O
is	O
common	O
after	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
(	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
)	O
,	O
its	O
relationship	O
to	O
mortality	O
,	O
progressive	O
kidney	O
disease	I:C0022658
,	O
or	O
the	O
development	O
of	O
end	B:C0022661
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
(	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
)	O
is	O
not	O
well	O
-	O
described	O
.	O

Although	O
hyperuricemia	O
is	O
common	O
after	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
(	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
)	O
,	O
its	O
relationship	O
to	O
mortality	O
,	O
progressive	O
kidney	O
disease	I:C0022658
,	O
or	O
the	O
development	O
of	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
(	O
end	B:C0022661
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
)	O
is	O
not	O
well	O
-	O
described	O
.	O

Data	O
from	O
304	O
patients	O
undergoing	O
orthotopic	B:C0400447
liver	I:C0400447
transplantation	I:C0400447
between	O
1996	O
and	O
2010	O
were	O
used	O
to	O
assess	O
the	O
association	O
of	O
mean	O
serum	O
uric	O
acid	I:C0041980
(	O
uric	O
acid	I:C0041980
)	O
level	O
in	O
the	O
3	O
-	O
months	O
post	O
-	O
OLT	O
with	O
mortality	O
,	O
doubling	O
of	O
creatinine	O
,	O
and	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
incidence	O
.	O

Data	O
from	O
304	O
patients	O
undergoing	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
between	O
1996	O
and	O
2010	O
were	O
used	O
to	O
assess	O
the	O
association	O
of	O
mean	O
serum	B:C0229671
uric	O
acid	I:C0041980
(	O
uric	O
acid	I:C0041980
)	O
level	O
in	O
the	O
3	O
-	O
months	O
post	O
-	O
OLT	O
with	O
mortality	O
,	O
doubling	O
of	O
creatinine	O
,	O
and	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
incidence	O
.	O

Data	O
from	O
304	O
patients	O
undergoing	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
between	O
1996	O
and	O
2010	O
were	O
used	O
to	O
assess	O
the	O
association	O
of	O
mean	O
serum	O
uric	B:C0041980
acid	I:C0041980
(	O
uric	O
acid	I:C0041980
)	O
level	O
in	O
the	O
3	O
-	O
months	O
post	O
-	O
OLT	O
with	O
mortality	O
,	O
doubling	O
of	O
creatinine	O
,	O
and	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
incidence	O
.	O

Data	O
from	O
304	O
patients	O
undergoing	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
between	O
1996	O
and	O
2010	O
were	O
used	O
to	O
assess	O
the	O
association	O
of	O
mean	O
serum	O
uric	O
acid	I:C0041980
(	O
uric	B:C0041980
acid	I:C0041980
)	O
level	O
in	O
the	O
3	O
-	O
months	O
post	O
-	O
OLT	O
with	O
mortality	O
,	O
doubling	O
of	O
creatinine	O
,	O
and	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
incidence	O
.	O

Data	O
from	O
304	O
patients	O
undergoing	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
between	O
1996	O
and	O
2010	O
were	O
used	O
to	O
assess	O
the	O
association	O
of	O
mean	O
serum	O
uric	O
acid	I:C0041980
(	O
uric	O
acid	I:C0041980
)	O
level	O
in	O
the	O
3	O
-	O
months	O
post	O
-	O
OLT	O
with	O
mortality	O
,	O
doubling	O
of	O
creatinine	B:C0010294
,	O
and	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
incidence	O
.	O

Data	O
from	O
304	O
patients	O
undergoing	O
orthotopic	O
liver	I:C0400447
transplantation	I:C0400447
between	O
1996	O
and	O
2010	O
were	O
used	O
to	O
assess	O
the	O
association	O
of	O
mean	O
serum	O
uric	O
acid	I:C0041980
(	O
uric	O
acid	I:C0041980
)	O
level	O
in	O
the	O
3	O
-	O
months	O
post	O
-	O
OLT	O
with	O
mortality	O
,	O
doubling	O
of	O
creatinine	O
,	O
and	O
end	B:C0022661
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
incidence	O
.	O

Post	O
-	O
OLT	O
survival	O
to	O
event	O
outcomes	O
according	O
to	O
uric	B:C0041980
acid	I:C0041980
level	O
and	O
eGFR	O
was	O
assessed	O
using	O
the	O
Kaplan	O
Meier	I:C2827659
method	I:C2827659
and	O
multivariate	O
Cox	I:C0010235
proportional	I:C0010235
hazards	I:C0010235
models	I:C0010235
.	O

Post	O
-	O
OLT	O
survival	O
to	O
event	O
outcomes	O
according	O
to	O
uric	O
acid	I:C0041980
level	O
and	O
eGFR	B:C3811844
was	O
assessed	O
using	O
the	O
Kaplan	O
Meier	I:C2827659
method	I:C2827659
and	O
multivariate	O
Cox	I:C0010235
proportional	I:C0010235
hazards	I:C0010235
models	I:C0010235
.	O

Post	O
-	O
OLT	O
survival	O
to	O
event	O
outcomes	O
according	O
to	O
uric	O
acid	I:C0041980
level	O
and	O
eGFR	O
was	O
assessed	O
using	O
the	O
Kaplan	B:C2827659
Meier	I:C2827659
method	I:C2827659
and	O
multivariate	O
Cox	I:C0010235
proportional	I:C0010235
hazards	I:C0010235
models	I:C0010235
.	O

Post	O
-	O
OLT	O
survival	O
to	O
event	O
outcomes	O
according	O
to	O
uric	O
acid	I:C0041980
level	O
and	O
eGFR	O
was	O
assessed	O
using	O
the	O
Kaplan	O
Meier	I:C2827659
method	I:C2827659
and	O
multivariate	B:C0010235
Cox	I:C0010235
proportional	I:C0010235
hazards	I:C0010235
models	I:C0010235
.	O

Mean	O
uric	B:C0041980
acid	I:C0041980
level	O
among	O
the	O
204	O
patients	O
with	O
an	O
eGFR	O
level	O
≥	O
60	O
ml/min/1.73	O
m	O
(	O
2	O
)	O
was	O
6.4	O
mg	O
/	O
dl	O
compared	O
to	O
7.9	O
mg	O
/dl	O
among	O
the	O
100	O
patients	O
with	O
eGFR	O
<	O
60	O
(	O
p	O
<	O
0.0001	O
)	O
.	O

Mean	O
uric	O
acid	I:C0041980
level	O
among	O
the	O
204	O
patients	O
with	O
an	O
eGFR	B:C3811844
level	O
≥	O
60	O
ml/min/1.73	O
m	O
(	O
2	O
)	O
was	O
6.4	O
mg	O
/	O
dl	O
compared	O
to	O
7.9	O
mg	O
/dl	O
among	O
the	O
100	O
patients	O
with	O
eGFR	O
<	O
60	O
(	O
p	O
<	O
0.0001	O
)	O
.	O

Mean	O
uric	O
acid	I:C0041980
level	O
among	O
the	O
204	O
patients	O
with	O
an	O
eGFR	O
level	O
≥	O
60	O
ml/min/1.73	O
m	O
(	O
2	O
)	O
was	O
6.4	O
mg	O
/	O
dl	O
compared	O
to	O
7.9	O
mg	O
/dl	O
among	O
the	O
100	O
patients	O
with	O
eGFR	B:C3811844
<	O
60	O
(	O
p	O
<	O
0.0001	O
)	O
.	O

During	O
a	O
median	B:C0549183
of	O
4.6	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
,	O
mortality	O
rate	O
,	O
doubling	O
of	O
creatinine	O
,	O
and	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
incidence	O
were	O
48.9	O
,	O
278.2	O
,	O
and	O
20.7	O
per	O
1000	O
person	O
-	O
years	O
,	O
respectively	O
.	O

During	O
a	O
median	O
of	O
4.6	O
years	O
of	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
,	O
mortality	O
rate	O
,	O
doubling	O
of	O
creatinine	O
,	O
and	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
incidence	O
were	O
48.9	O
,	O
278.2	O
,	O
and	O
20.7	O
per	O
1000	O
person	O
-	O
years	O
,	O
respectively	O
.	O

During	O
a	O
median	O
of	O
4.6	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
,	O
mortality	O
rate	O
,	O
doubling	O
of	O
creatinine	B:C0010294
,	O
and	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
incidence	O
were	O
48.9	O
,	O
278.2	O
,	O
and	O
20.7	O
per	O
1000	O
person	O
-	O
years	O
,	O
respectively	O
.	O

During	O
a	O
median	O
of	O
4.6	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
,	O
mortality	O
rate	O
,	O
doubling	O
of	O
creatinine	O
,	O
and	O
end	B:C0022661
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
incidence	O
were	O
48.9	O
,	O
278.2	O
,	O
and	O
20.7	O
per	O
1000	O
person	O
-	O
years	O
,	O
respectively	O
.	O

During	O
a	O
median	O
of	O
4.6	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
,	O
mortality	O
rate	O
,	O
doubling	O
of	O
creatinine	O
,	O
and	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
incidence	O
were	O
48.9	O
,	O
278.2	O
,	O
and	O
20.7	O
per	O
1000	O
person	B:C0027361
-	O
years	O
,	O
respectively	O
.	O

In	O
the	O
first	O
5	O
years	O
of	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
,	O
elevated	O
uric	O
acid	I:C0041980
was	O
associated	O
with	O
mortality	O
(	O
Hazard	O
Ratio	O
,	O
HR	O
=	O
1.7	O
;	O
p	O
=	O
0.045	O
)	O
.	O

In	O
the	O
first	O
5	O
years	O
of	O
follow	O
-	I:C1522577
up	I:C1522577
,	O
elevated	O
uric	B:C0041980
acid	I:C0041980
was	O
associated	O
with	O
mortality	O
(	O
Hazard	O
Ratio	O
,	O
HR	O
=	O
1.7	O
;	O
p	O
=	O
0.045	O
)	O
.	O

However	O
,	O
among	O
those	O
with	O
eGFR	B:C3811844
≥	O
60	O
,	O
uric	O
acid	I:C0041980
level	O
did	O
not	O
predict	O
mortality	O
(	O
HR	O
=	O
1.0	O
;	O
p	O
=	O
0.95	O
)	O
,	O
and	O
among	O
those	O
with	O
eGFR	O
<	O
60	O
,	O
elevated	O
uric	O
acid	I:C0041980
was	O
a	O
strong	O
predictor	O
of	O
mortality	O
(	O
HR	O
=	O
3.7	O
[	O
1.1	O
,	O
12.0	O
]	O
;	O
p	O
=	O
0.03	O
)	O
.	O

However	O
,	O
among	O
those	O
with	O
eGFR	O
≥	O
60	O
,	O
uric	B:C0041980
acid	I:C0041980
level	O
did	O
not	O
predict	O
mortality	O
(	O
HR	O
=	O
1.0	O
;	O
p	O
=	O
0.95	O
)	O
,	O
and	O
among	O
those	O
with	O
eGFR	O
<	O
60	O
,	O
elevated	O
uric	O
acid	I:C0041980
was	O
a	O
strong	O
predictor	O
of	O
mortality	O
(	O
HR	O
=	O
3.7	O
[	O
1.1	O
,	O
12.0	O
]	O
;	O
p	O
=	O
0.03	O
)	O
.	O

However	O
,	O
among	O
those	O
with	O
eGFR	O
≥	O
60	O
,	O
uric	O
acid	I:C0041980
level	O
did	O
not	O
predict	O
mortality	O
(	O
HR	O
=	O
1.0	O
;	O
p	O
=	O
0.95	O
)	O
,	O
and	O
among	O
those	O
with	O
eGFR	B:C3811844
<	O
60	O
,	O
elevated	O
uric	O
acid	I:C0041980
was	O
a	O
strong	O
predictor	O
of	O
mortality	O
(	O
HR	O
=	O
3.7	O
[	O
1.1	O
,	O
12.0	O
]	O
;	O
p	O
=	O
0.03	O
)	O
.	O

However	O
,	O
among	O
those	O
with	O
eGFR	O
≥	O
60	O
,	O
uric	O
acid	I:C0041980
level	O
did	O
not	O
predict	O
mortality	O
(	O
HR	O
=	O
1.0	O
;	O
p	O
=	O
0.95	O
)	O
,	O
and	O
among	O
those	O
with	O
eGFR	O
<	O
60	O
,	O
elevated	O
uric	B:C0041980
acid	I:C0041980
was	O
a	O
strong	O
predictor	O
of	O
mortality	O
(	O
HR	O
=	O
3.7	O
[	O
1.1	O
,	O
12.0	O
]	O
;	O
p	O
=	O
0.03	O
)	O
.	O

uric	B:C0041980
acid	I:C0041980
was	O
not	O
associated	O
with	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
,	O
but	O
was	O
associated	O
with	O
doubling	O
of	O
creatinine	O
among	O
diabetics	O
(	O
HR	O
=	O
2.2	O
[	O
1.1	O
,	O
4.3	O
]	O
;	O
p	O
=	O
0.025	O
)	O
.	O

uric	O
acid	I:C0041980
was	O
not	O
associated	O
with	O
end	B:C0022661
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
,	O
but	O
was	O
associated	O
with	O
doubling	O
of	O
creatinine	O
among	O
diabetics	O
(	O
HR	O
=	O
2.2	O
[	O
1.1	O
,	O
4.3	O
]	O
;	O
p	O
=	O
0.025	O
)	O
.	O

uric	O
acid	I:C0041980
was	O
not	O
associated	O
with	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
,	O
but	O
was	O
associated	O
with	O
doubling	O
of	O
creatinine	B:C0010294
among	O
diabetics	O
(	O
HR	O
=	O
2.2	O
[	O
1.1	O
,	O
4.3	O
]	O
;	O
p	O
=	O
0.025	O
)	O
.	O

uric	O
acid	I:C0041980
was	O
not	O
associated	O
with	O
end	O
stage	I:C0022661
renal	I:C0022661
disease	I:C0022661
,	O
but	O
was	O
associated	O
with	O
doubling	O
of	O
creatinine	O
among	O
diabetics	B:C0011847
(	O
HR	O
=	O
2.2	O
[	O
1.1	O
,	O
4.3	O
]	O
;	O
p	O
=	O
0.025	O
)	O
.	O

In	O
this	O
post	O
-	O
OLT	O
cohort	B:C0599755
,	O
hyperuricemia	O
independently	O
predicted	O
mortality	O
,	O
particularly	O
among	O
patients	O
with	O
eGFR	O
<	O
60	O
,	O
and	O
predicted	O
doubling	O
of	O
creatinine	O
among	O
diabetics	O
.	O

In	O
this	O
post	O
-	O
OLT	O
cohort	O
,	O
hyperuricemia	B:C0740394
independently	O
predicted	O
mortality	O
,	O
particularly	O
among	O
patients	O
with	O
eGFR	O
<	O
60	O
,	O
and	O
predicted	O
doubling	O
of	O
creatinine	O
among	O
diabetics	O
.	O

In	O
this	O
post	O
-	O
OLT	O
cohort	O
,	O
hyperuricemia	O
independently	O
predicted	O
mortality	O
,	O
particularly	O
among	O
patients	O
with	O
eGFR	B:C3811844
<	O
60	O
,	O
and	O
predicted	O
doubling	O
of	O
creatinine	O
among	O
diabetics	O
.	O

In	O
this	O
post	O
-	O
OLT	O
cohort	O
,	O
hyperuricemia	O
independently	O
predicted	O
mortality	O
,	O
particularly	O
among	O
patients	O
with	O
eGFR	O
<	O
60	O
,	O
and	O
predicted	O
doubling	O
of	O
creatinine	B:C0010294
among	O
diabetics	O
.	O

In	O
this	O
post	O
-	O
OLT	O
cohort	O
,	O
hyperuricemia	O
independently	O
predicted	O
mortality	O
,	O
particularly	O
among	O
patients	O
with	O
eGFR	O
<	O
60	O
,	O
and	O
predicted	O
doubling	O
of	O
creatinine	O
among	O
diabetics	B:C0011847
.	O

